Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma

• Published in: Surgical oncology 2022-05, Vol.41, p.101730-101730, Article 101730
• Main Authors: D'Silva, Mizelle, Cho, Jai Young, Han, Ho-Seong, Yoon, Yoo-Seok, Lee, Hae Won, Lee, Jun Suh, Lee, Boram, Kim, Moonhwan
• Format: Article
• Language: English
• Subjects: Anatomical liver resection; Body mass index; Carcinoma, Hepatocellular - epidemiology; Carcinoma, Hepatocellular - etiology; Carcinoma, Hepatocellular - surgery; Cirrhosis; Cryptogenic; Fatty liver; Hepatectomy; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatocellular carcinoma; Hospitals; Humans; Infections; Inflammation; Laboratories; Liver; Liver cancer; Liver cirrhosis; Liver Cirrhosis - complications; Liver diseases; Liver Neoplasms - epidemiology; Liver Neoplasms - etiology; Liver Neoplasms - surgery; Medical prognosis; Multivariate analysis; Nodules; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - surgery; Non-alcoholic steatohepatitis; Patients; Rank tests; Regression analysis; Regression models; Retrospective Studies; Risk Factors; Serology; Statistical analysis; Surgery; Surgical outcomes; Survival; Systemic disease-free survival; Systemic diseases; Thrombocytopenia; Treatment Outcome; Tumors; Viruses
• ISSN: 0960-7404; 1879-3320
• DOI: 10.1016/j.suronc.2022.101730

The global burden of non-alcoholic fatty liver disease (NAFLD) and NAFLD-associated hepatocellular carcinoma (HCC) is steadily rising. We pursued to investigate the results after liver resection for NAFLD-HCC versus hepatitis B virus (HBV)-HCC exploiting Kaplan Meier method, log-rank test and uni/multivariate analysis with the logistic regression models”. Patients who underwent liver resection for HCC between January 2004 and December 2018 were included. The outcomes of NAFLD-associated HCC were analyzed. The prevalence of NAFLD-associated HCC was 8.4%. A significant number of NAFLD patients had no cirrhosis (21 patients; 38.8%). Although NAFLD patients had a significantly better 5-year survival (P = 0.033), NAFLD was not significantly associated with overall survival in multivariate analysis (P = 0.287). However, survival after 5 years declined in NAFLD patients and was similar to HBV. NAFLD was protective against systemic recurrence compared with HBV (P = 0.018), and this was confirmed in multivariate analysis (P = 0.044). Five-year systemic recurrence (P = 0.044) was significantly lower in NAFLD patients and decreased with time from surgery. Multivariate analysis revealed that anatomical liver resection was independently associated with decreased recurrence in NAFLD patients (HR = 0.337; P = 0.033). Overall survival is similar between NAFLD-associated HCC and HBV-associated HCC. Despite there being no significant difference between liver function tests, type of surgery performed, liver cirrhosis, size of tumor, number of tumors, pathological factors like satellite nodules and Edmonson Steiner staging, NAFLD-associated HCC shows lower systemic recurrence compared to HBV-associated HCC. [Display omitted] •As the global burden of NAFLD rises, factors affecting survival of HCC patients associated with NAFLD must be assessed.•NAFLD patients had a significantly better 5-year survival and NAFLD was protective against systemic recurrence compared with HBV.•Anatomical liver resection was the only factor independently associated with decreased recurrence in NAFLD patients.•Optimal long term outcomes are possible with appropriate, timely surgical management of NAFLD-associated HCC.